• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada.《2018年炎症性肠病在加拿大的影响:加拿大胃肠病流行病学联盟致加拿大克罗恩病与结肠炎协会的科学报告》
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S1-S5. doi: 10.1093/jcag/gwy052. Epub 2018 Nov 2.
2
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.2018年炎症性肠病对加拿大的影响:直接成本与医疗服务利用情况
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2.
3
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.《2018年炎症性肠病在加拿大的影响:患有炎症性肠病的儿童和青少年》
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2.
4
The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.《2018年炎症性肠病在加拿大的影响:流行病学》
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2.
5
The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD.《2023年炎症性肠病对加拿大的影响:炎症性肠病流行病学》
J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S9-S15. doi: 10.1093/jcag/gwad004. eCollection 2023 Sep.
6
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary.加拿大克罗恩病与结肠炎协会《2021年新冠疫情对加拿大炎症性肠病的影响:执行摘要》
J Can Assoc Gastroenterol. 2021 Nov 5;4(Suppl 2):S1-S9. doi: 10.1093/jcag/gwab027. eCollection 2021 Dec.
7
The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.《2018年炎症性肠病在加拿大的影响:老年人中的炎症性肠病》
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S68-S72. doi: 10.1093/jcag/gwy051. Epub 2018 Nov 2.
8
The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.2018年炎症性肠病在加拿大的影响:加拿大炎症性肠病研究概况
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S81-S91. doi: 10.1093/jcag/gwy057. Epub 2018 Nov 2.
9
The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.2018年加拿大炎症性肠病的影响:生活质量
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S42-S48. doi: 10.1093/jcag/gwy048. Epub 2018 Nov 2.
10
Inflammatory bowel disease: a Canadian burden of illness review.炎症性肠病:加拿大疾病负担综述
Can J Gastroenterol. 2012 Nov;26(11):811-7. doi: 10.1155/2012/984575.

引用本文的文献

1
Assessing the socioeconomic burden in pediatric inflammatory bowel disease-a survey of families and national providers.评估儿童炎症性肠病的社会经济负担——一项针对家庭和全国医疗服务提供者的调查。
J Can Assoc Gastroenterol. 2025 May 23;8(4):128-135. doi: 10.1093/jcag/gwaf007. eCollection 2025 Aug.
2
Frequency enrichment of coding variants in a French-Canadian founder population and its implication for inflammatory bowel diseases.法裔加拿大奠基者人群中编码变异的频率富集及其对炎症性肠病的影响。
medRxiv. 2025 Jul 14:2025.07.11.25331388. doi: 10.1101/2025.07.11.25331388.
3
Targeting Bile-Acid Metabolism: Nutritional and Microbial Approaches to Alleviate Ulcerative Colitis.靶向胆汁酸代谢:缓解溃疡性结肠炎的营养和微生物学方法
Nutrients. 2025 Mar 28;17(7):1174. doi: 10.3390/nu17071174.
4
From Evidence to Practice: A Narrative Framework for Integrating the Mediterranean Diet into Inflammatory Bowel Disease Management.从证据到实践:将地中海饮食纳入炎症性肠病管理的叙事框架
Nutrients. 2025 Jan 28;17(3):470. doi: 10.3390/nu17030470.
5
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis.炎症性肠病临床试验中入选标准的演变:一项临床试验数据库分析
United European Gastroenterol J. 2025 May;13(4):542-551. doi: 10.1002/ueg2.12731. Epub 2024 Dec 19.
6
Real-world experience and long-term outcomes of a mandatory non-medical switch of adalimumab originator to biosimilars in inflammatory bowel disease.阿达木单抗原研药强制非医学转换为生物类似药在炎症性肠病中的真实世界经验和长期结果
World J Gastroenterol. 2024 Dec 14;30(46):4904-4913. doi: 10.3748/wjg.v30.i46.4904.
7
Inflammatory bowel disease uncovered in fecal immunochemical test positive patients in a Canadian provincial colon cancer screening program.在加拿大省级结肠癌筛查计划中,粪便免疫化学检测阳性的患者中发现炎症性肠病。
Sci Rep. 2024 Oct 3;14(1):22967. doi: 10.1038/s41598-024-73817-7.
8
A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease.炎症性肠病现代治疗时代患者关切问题的研究
Inflamm Bowel Dis. 2025 Jun 13;31(6):1595-1604. doi: 10.1093/ibd/izae197.
9
Evaluating Inflammatory Bowel Disease-Related Quality of Life Using an Interpretable Machine Learning Approach: A Multicenter Study in China.使用可解释机器学习方法评估炎症性肠病相关生活质量:一项中国多中心研究
J Inflamm Res. 2024 Aug 9;17:5271-5283. doi: 10.2147/JIR.S470197. eCollection 2024.
10
Exploration and verification a 13-gene diagnostic framework for ulcerative colitis across multiple platforms via machine learning algorithms.基于机器学习算法的多平台溃疡性结肠炎 13 基因诊断框架的探索与验证。
Sci Rep. 2024 Jul 1;14(1):15009. doi: 10.1038/s41598-024-65481-8.

本文引用的文献

1
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率:基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
2
Review article: changes in the epidemiology of inflammatory bowel disease-clues for aetiology.综述文章:炎症性肠病流行病学的变化——病因学线索
Aliment Pharmacol Ther. 2017 Nov;46(10):911-919. doi: 10.1111/apt.14338. Epub 2017 Sep 26.
3
Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.早年的城乡居住情况与炎症性肠病风险相关:一项基于人群的起始队列和出生队列研究。
Am J Gastroenterol. 2017 Sep;112(9):1412-1422. doi: 10.1038/ajg.2017.208. Epub 2017 Jul 25.
4
Cost of Ulcerative Colitis in Quebec, Canada: A Retrospective Cohort Study.加拿大魁北克省溃疡性结肠炎的成本:一项回顾性队列研究。
Inflamm Bowel Dis. 2017 Aug;23(8):1262-1271. doi: 10.1097/MIB.0000000000001147.
5
Disability in Patients with Inflammatory Bowel Disease: Correlations with Quality of Life and Patient's Characteristics.炎症性肠病患者的残疾状况:与生活质量和患者特征的相关性。
Can J Gastroenterol Hepatol. 2017;2017:6138105. doi: 10.1155/2017/6138105. Epub 2017 May 29.
6
Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.加拿大儿童炎症性肠病的流行病学趋势:基于多个人口的省级卫生行政数据库的分布式网络分析
Am J Gastroenterol. 2017 Jul;112(7):1120-1134. doi: 10.1038/ajg.2017.97. Epub 2017 Apr 18.
7
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.新诊断为克罗恩病儿童复杂疾病病程的预测:一项多中心发病队列研究。
Lancet. 2017 Apr 29;389(10080):1710-1718. doi: 10.1016/S0140-6736(17)30317-3. Epub 2017 Mar 2.
8
Quality of life and uncertainty in Crohn's disease.克罗恩病患者的生活质量与不确定性
Qual Life Res. 2017 Jun;26(6):1609-1616. doi: 10.1007/s11136-017-1509-5. Epub 2017 Feb 8.
9
Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.癫痫的患病率和发病率:国际研究的系统评价与荟萃分析
Neurology. 2017 Jan 17;88(3):296-303. doi: 10.1212/WNL.0000000000003509. Epub 2016 Dec 16.
10
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.了解和预防炎症性肠病的全球增长。
Gastroenterology. 2017 Feb;152(2):313-321.e2. doi: 10.1053/j.gastro.2016.10.020. Epub 2016 Oct 25.

《2018年炎症性肠病在加拿大的影响:加拿大胃肠病流行病学联盟致加拿大克罗恩病与结肠炎协会的科学报告》

The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada.

作者信息

Benchimol Eric I, Bernstein Charles N, Bitton Alain, Murthy Sanjay K, Nguyen Geoffrey C, Lee Kate, Cooke-Lauder Jane, Siddiq Shabnaz, Windsor Joseph W, Carroll Matthew W, Coward Stephanie, El-Matary Wael, Griffiths Anne M, Jones Jennifer L, Kuenzig M Ellen, Lee Lawrence, Mack David R, Mawani Mina, Otley Anthony R, Singh Harminder, Targownik Laura E, Weizman Adam V, Kaplan Gilaad G

机构信息

Canadian Gastro-Intestinal Epidemiology Consortium, Canada.

Children's Hospital of Eastern Ontario IBD Centre, Department of Pediatrics and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

出版信息

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S1-S5. doi: 10.1093/jcag/gwy052. Epub 2018 Nov 2.

DOI:10.1093/jcag/gwy052
PMID:31294380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6512240/
Abstract

Canada has among the highest rates of IBD in the world, and the number of people living with these disorders is growing rapidly. This has placed a high burden on the health care system and on the Canadian economy-a burden that is only expected to grow in the future. It is important to understand IBD and its impact on Canadian society in order to appropriately plan for health care expenditures, reduce the burden on patients and their families, and improve the quality of life for those afflicted with IBD. In Canada, there is a lack of public awareness of the impact of Crohn's disease and ulcerative colitis. Raising awareness is crucial to reducing the social stigma that is common with these diseases and to help individuals maximize their overall quality of life. A better public understanding of IBD can also help to raise and direct funds for research, which could lead to improved treatments and, ultimately, to a cure. This report from Canadian clinicians and researchers to Crohn's and Colitis Canada makes recommendations aimed at the public, policy-makers, scientific funding agencies, charitable foundations and patients regarding future directions for advocacy efforts and areas to emphasize for research spending. The report also identifies gaps in knowledge in the fields of clinical, health systems and epidemiological research.

摘要

加拿大是全球炎症性肠病发病率最高的国家之一,患这些疾病的人数正在迅速增加。这给医疗保健系统和加拿大经济带来了沉重负担,而且预计这一负担在未来还会加重。了解炎症性肠病及其对加拿大社会的影响,对于合理规划医疗保健支出、减轻患者及其家庭的负担以及提高炎症性肠病患者的生活质量至关重要。在加拿大,公众对克罗恩病和溃疡性结肠炎的影响缺乏认识。提高认识对于减少这些疾病常见的社会耻辱感以及帮助个人最大限度地提高整体生活质量至关重要。公众对炎症性肠病有更好的了解,也有助于筹集和引导研究资金,这可能会带来更好的治疗方法,并最终实现治愈。这份由加拿大临床医生和研究人员提交给加拿大克罗恩病与结肠炎协会的报告,针对公众、政策制定者、科学资助机构、慈善基金会和患者,就未来宣传工作的方向以及研究支出应重点关注的领域提出了建议。该报告还指出了临床、卫生系统和流行病学研究领域的知识空白。